J&J/Ethicon
This article was originally published in The Tan Sheet
Executive Summary
Wound care division will "phase out production and marketing of selected general wound care product lines - including eye pads, sponges, gauze pads, tapes and cleaners - in the U.S. within the next six months," firm says in July 1 letter to distributors. J&J/Ethicon instead will focus on developing drug/device combination products for advanced wound care, such as Band-Aid liquid bandage and Dermabond topical skin adhesive, which are manufactured by Closure Medical and marketed by J&J (1"The Tan Sheet" March 18, 2002, p. 19). Several Band-Aid products, such as Steri-Pad gauze pads, are affected by the phase-out, which includes 36 brands. J&J/Ethicon plans to close its manufacturing facility in Sherman, Texas by Dec. 31 and says the move will affect roughly 510 employees at the plant...
You may also be interested in...
J&J Band-Aid Liquid Bandage Labeling Stresses “Fast Healing” Benefits
Band-Aid Liquid Bandage is reaching food, drug and mass shelves now after shipping in late February, according to Johnson & Johnson Consumer Products
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.